Phase 4 Obesity trials recruiting now

All Obesity trials, every phase

Other phases for Obesity

Phase 4 Obesity trials

• 2024 Tirzepatide-Bariatric Surgery
  NCT06721507 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
  NCT07326111 · Phase: Phase 4 · Ages: 18 Years to 45 Years · Sex: Female · 2 locations
• A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
  NCT07728383 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
  NCT07247084 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
  NCT06864026 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 55 locations
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 39 locations
• Bioenergetic Effects of Aging and Menopause (BEAM)
  NCT04043520 · Phase: Phase 4 · Ages: 40 Years to 65 Years · Sex: Female · 1 location
• Cardiometabolic Consequences of the Loss of Ovarian Function
  NCT06264882 · Phase: Phase 4 · Ages: 20 Years to 45 Years · Sex: Female · 1 location
• DUTCH Weight Control in Atrial Fibrillation Study
  NCT06184633 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
  NCT07136714 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
  NCT07073846 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
  NCT07242534 · Phase: Phase 4 · Ages: 18 Years to 38 Years · Sex: Female · 5 locations
• Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
  NCT06410352 · Phase: Phase 4 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
  NCT06782139 · Phase: Phase 4 · Ages: 20 Years to 79 Years · Sex: All (male and female) · 1 location
• Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
  NCT07401992 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
  NCT03851627 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: Male · 1 location
• Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients
  NCT06707012 · Phase: Phase 4 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 4 locations
• Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
  NCT07588438 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
  NCT07163650 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia Delivery System
  NCT05305313 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Fibrosis Lessens After Metabolic Surgery
  NCT06374875 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 22 locations
• GLP-1R Actions on Muscle and the Skeleton
  NCT07154719 · Phase: Phase 4 · Ages: 18 Years to 50 Years · Sex: All (male and female) · 2 locations
• Impact GLP-1 Agonists Following Bariatric
  NCT06132477 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Impact of Semaglutide on Tobacco Use and Related Health Behaviors
  NCT06986993 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Incretin Therapies in Obesity-related HFpEF
  NCT07554638 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · 2 locations
• Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
  NCT07213466 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
  NCT06852391 · Phase: Phase 4 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 1 location
• Knee Injections for Obese Patients With Knee Arthritis
  NCT06782529 · Phase: Phase 4 · Ages: 55 Years to 85 Years · Sex: All (male and female) · 2 locations
• Liraglutide Treatment in Obese Infertile PCOS Women
  NCT06742710 · Phase: Phase 4 · Ages: 20 Years to 40 Years · Sex: Female · 3 locations
• Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
  NCT03087032 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
  NCT07513168 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity
  NCT06809166 · Phase: Phase 4 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 9 locations
• Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
  NCT05744479 · Phase: Phase 4 · Ages: 16 Years to 65 Years · Sex: All (male and female) · 1 location
• Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
  NCT06396416 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
  NCT07058155 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery
  NCT05975580 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
  NCT05838287 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · 1 location
• Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity
  NCT07674290 · Phase: Phase 4 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery
  NCT07098780 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
  NCT06191848 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass
  NCT05320796 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
  NCT07218445 · Phase: Phase 4 · Ages: 46 Years to 60 Years · Sex: Female · 1 location
• The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression
  NCT07699445 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
  NCT05051436 · Phase: Phase 4 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
  NCT06606821 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
  NCT07423247 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tirzepatide Use in People With Obesity and Type 1 Diabetes
  NCT07096908 · Phase: Phase 4 · Ages: 21 Years and older · Sex: All (male and female) · 1 location
• Tirzepatide in PWS, HO and GNSO
  NCT06901245 · Phase: Phase 4 · Ages: 18 Years to 26 Years · Sex: All (male and female) · 3 locations
• Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
  NCT07257484 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 2 locations
• Total-body Glucose Utilization in Obesity
  NCT06739473 · Phase: Phase 4 · Ages: 20 Years to 60 Years · Sex: All (male and female) · 1 location
• Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
  NCT07275697 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
  NCT05919797 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.